Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Partow Kebriaei

Showing results (51-60 of 346) with videos related to

Pageof 35
Sort By:
Journal of Geriatric Oncology|September 8, 2021
Serial frailty assessments following allogeneic stem cell transplant in older adults: A pilot studyRachel Ombres, Jude K A des Bordes, Uday R Popat, et al.
Cancer|December 18, 2008
Therapy-related acute myelogenous leukemia and myelodysplastic syndrome in patients with acute lymphoblastic leukemia treated with the hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone regimensDushyant Verma, Susan O'Brien, Deborah Thomas, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|April 19, 2018
Graft loss attributed to possible transfusion-transmitted ehrlichiosis following cord blood stem cell transplantAllison Mah, George M Viola, Ella Ariza Heredia, et al.
Leukemia & Lymphoma|June 28, 2016
Stem cell transplantation outcomes in lymphoblastic lymphomaJonathan E Brammer, Issa Khouri, David Marin, et al.
Journal of Medical Case Reports|July 29, 2016
Graft-versus-host disease after radiation therapy in patients who have undergone allogeneic stem cell transplantation: two case reportsSarah A Milgrom, Yago Nieto, Chelsea C Pinnix, et al.
Cancer|February 24, 2009
Low-dose azacitidine after allogeneic stem cell transplantation for acute leukemiaElias Jabbour, Sergio Giralt, Hagop Kantarjian, et al.
Clinical Lymphoma, Myeloma & Leukemia|January 15, 2013
Feasibility of allografting in patients with advanced acute lymphoblastic leukemia after salvage therapy with inotuzumab ozogamicinPartow Kebriaei, Kaci Wilhelm, Farhad Ravandi, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 6, 2020
Chimeric Antigen Receptor Therapy: How Are We Driving in Solid Tumors?Uri Greenbaum, Fevzi F Yalniz, Samer A Srour, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 23, 2009
Adult human mesenchymal stem cells added to corticosteroid therapy for the treatment of acute graft-versus-host diseasePartow Kebriaei, Luis Isola, Erkut Bahceci, et al.
Journal of Hematology & Oncology|April 20, 2026
Uncoupling toxicity from efficacy in donor selection for allogeneic hematopoietic cell transplantation: a retrospective cohort study using double machine learningRohtesh S Mehta, Yosra M Aljawai, Warren Fingrut, et al.
Pageof 35

Showing results (51-60 of 346) with videos related to

Sort By:
Pageof 35
Journal of Geriatric Oncology|September 8, 2021
Serial frailty assessments following allogeneic stem cell transplant in older adults: A pilot studyRachel Ombres, Jude K A des Bordes, Uday R Popat, et al.
Cancer|December 18, 2008
Therapy-related acute myelogenous leukemia and myelodysplastic syndrome in patients with acute lymphoblastic leukemia treated with the hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone regimensDushyant Verma, Susan O'Brien, Deborah Thomas, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|April 19, 2018
Graft loss attributed to possible transfusion-transmitted ehrlichiosis following cord blood stem cell transplantAllison Mah, George M Viola, Ella Ariza Heredia, et al.
Leukemia & Lymphoma|June 28, 2016
Stem cell transplantation outcomes in lymphoblastic lymphomaJonathan E Brammer, Issa Khouri, David Marin, et al.
Journal of Medical Case Reports|July 29, 2016
Graft-versus-host disease after radiation therapy in patients who have undergone allogeneic stem cell transplantation: two case reportsSarah A Milgrom, Yago Nieto, Chelsea C Pinnix, et al.
Cancer|February 24, 2009
Low-dose azacitidine after allogeneic stem cell transplantation for acute leukemiaElias Jabbour, Sergio Giralt, Hagop Kantarjian, et al.
Clinical Lymphoma, Myeloma & Leukemia|January 15, 2013
Feasibility of allografting in patients with advanced acute lymphoblastic leukemia after salvage therapy with inotuzumab ozogamicinPartow Kebriaei, Kaci Wilhelm, Farhad Ravandi, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 6, 2020
Chimeric Antigen Receptor Therapy: How Are We Driving in Solid Tumors?Uri Greenbaum, Fevzi F Yalniz, Samer A Srour, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 23, 2009
Adult human mesenchymal stem cells added to corticosteroid therapy for the treatment of acute graft-versus-host diseasePartow Kebriaei, Luis Isola, Erkut Bahceci, et al.
Journal of Hematology & Oncology|April 20, 2026
Uncoupling toxicity from efficacy in donor selection for allogeneic hematopoietic cell transplantation: a retrospective cohort study using double machine learningRohtesh S Mehta, Yosra M Aljawai, Warren Fingrut, et al.
Pageof 35